Indivior PLC
Change company Symbol lookup
Select an option...
INVVY Indivior PLC
F Ford Motor Co
TXRH Texas Roadhouse Inc
BCCI Baristas Coffee Company Inc
GOLDX Gabelli Gold Fund Class AAA
BIGRX American Century Disciplined Core Value Fund Investor Class
XOM Exxon Mobil Corp
COLFF Colabor Group Inc
BIO Bio Rad Laboratories Inc
RLGY Realogy Holdings Corp
Go

Health Care : Pharmaceuticals | Small Cap Blend
Based in United Kingdom
Company profile

Indivior PLC (Indivior) is a specialty pharmaceutical company. The Company is engaged in the development, manufacture and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence (the Indivior Business). Its treatment and pipeline focus is opioid use disorder, alcohol use disorder, overdose rescue and central nervous system (CNS) disorders/schizophrenia. Its products are Suboxone Film (buprenorphine and naloxone), Suboxone Tablet (buprenorphine and naloxone), and Subutex Tablet (buprenorphine). Its other products include RBP-6000 in ATRIGEL, RBP-7000 risperidone monthly depot, Arbaclofen placarbil for alcohol use disorder (AUD), Intranasal naloxone for treatment of opioid overdose and RBP-8000 cocaine esterase for cocaine intoxication. Its RBP-6000 buprenorphine monthly depot is developed for the treatment of opioid use disorder. Its RBP-7000 risperidone monthly depot is developed for treatment of schizophrenia.

This security is an American depositary receipt
ADR Fees
American Depositary Receipt (ADR) Fee

ADR fees charged by custodial banks normally average from 1 to 3 cents per share. Other country fees might apply. To read more, see the Exception Fees tab at Brokerage Fees

Price
Delayed
$7.17
Day's Change
-0.1272 (-1.74%)
Bid
--
Ask
--
B/A Size
--
Day's High
7.40
Day's Low
7.06
Volume
(Below Average)

Today's volume of 3,181 shares is on pace to be lower than INVVY's 10-day average volume of 8,570 shares.

3,181

Display:

Providers:

UpdateCancel
4 providers

No article found.

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.